Early brand building for pre-clinical asset

Early brand building for pre-clinical asset

Goal

The client wanted to understand potential future market scenarios for an asset in early phase I clinical development. There was a need to identify key areas of unmet need and decide on implications for development and target product profile (TPP) definition.

Approach

Standard of care

Analyze disease, SOC, patient journey and competitor landscape

Stakeholder needs

Map needs of all relevant stakeholders (regulators, payers, HCPs, patients)

TPP implications

Review TPP and define implications for clinical development

  • Defined 3 commercialization scenarios for the asset and implications for development
  • Reached consensus to change direction of development of the asset in order to better align with existing stakeholder needs

Learn more about this service

Lifecycle Management

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.

OK